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The main objective of this study is to demonstrate the performance characteristics of the Magic Plate 
(MP) system when operated upstream of the patient in transmission mode (MPTM). The MPTM is an 
essential component of a real-time QA system designed for operation during radiotherapy treatment. Of 
particular interest is a quantitative study into the influence of the MP on the radiation beam quality at 
several field sizes and linear accelerator potential differences. The impact is measured through beam 
perturbation effects such as changes in the skin dose and/or percentage depth dose (PDD) (both in and 
out of field). The MP was placed in the block tray of a Varian linac head operated at 6, 10 and 18 MV 
beam energy. To optimize the MPTM operational setup, two conditions were investigated and each setup 
was compared to the case where no MP is positioned in place (i.e., open field): (i) MPTM alone and (ii) 
MPTM with a thin passive contamination electron filter. The in-field and out-of-field surface doses of a 
solid water phantom were investigated for both setups using a Markus plane parallel (Model N23343) and 
Attix parallel-plate, MRI model 449 ionization chambers. In addition, the effect on the 2D dose distribution 
measured by the Delta4 QA system was also investigated. The transmission factor for both of these 
MPTM setups in the central axis was also investigated using a Farmer ionization chamber (Model 2571A) 
and an Attix ionization chamber. Measurements were performed for different irradiation field sizes of 5 x 
5 cm2 and 10 x 10 cm2. The change in the surface dose relative to dmax was measured to be less than 
0.5% for the 6 MV, 10 MV, and 18 MV energy beams. Transmission factors measured for both set ups (i & 
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open field. The impact of both the bare MPTM and the MPTM with 1 mm buildup on 3D dose distribution 
in comparison to the open field investigated using the Delta4 system and both the MPTM versions 
passed standard clinical gamma analysis criteria. Two MPTM operational setups were studied and 
presented in this article. The results indicate that both versions may be suitable for the new real-time 
megavoltage photon treatment delivery QA system under development. However, the bare MPTM appears 
to be slightly better suited of the two MP versions, as it minimally perturbs the radiation field and does not 
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The main objective of this study is to demonstrate the performance characteristics 
of the Magic Plate (MP) system when operated upstream of the patient in trans-
mission mode (MPTM). The MPTM is an essential component of a real-time QA 
system designed for operation during radiotherapy treatment. Of particular interest 
is a quantitative study into the influence of the MP on the radiation beam quality 
at several field sizes and linear accelerator potential differences. The impact is 
measured through beam perturbation effects such as changes in the skin dose and/
or percentage depth dose (PDD) (both in and out of field). The MP was placed in 
the block tray of a Varian linac head operated at 6, 10 and 18 MV beam energy. 
To optimize the MPTM operational setup, two conditions were investigated and 
each setup was compared to the case where no MP is positioned in place (i.e., open 
field): (i) MPTM alone and (ii) MPTM with a thin passive contamination electron 
filter. The in-field and out-of-field surface doses of a solid water phantom were 
investigated for both setups using a Markus plane parallel (Model N23343) and 
Attix parallel-plate, MRI model 449 ionization chambers. In addition, the effect 
on the 2D dose distribution measured by the Delta4 QA system was also investi-
gated. The transmission factor for both of these MPTM setups in the central axis 
was also investigated using a Farmer ionization chamber (Model 2571A) and an 
Attix ionization chamber. Measurements were performed for different irradiation 
field sizes of 5 × 5 cm2 and 10 × 10 cm2. The change in the surface dose relative to 
dmax was measured to be less than 0.5% for the 6 MV, 10 MV, and 18 MV energy 
beams. Transmission factors measured for both set ups (i & ii above) with 6 MV, 
10 MV, and 18 MV at a depth of dmax and a depth of 10 cm were all within 1.6% 
of open field. The impact of both the bare MPTM and the MPTM with 1 mm 
buildup on 3D dose distribution in comparison to the open field investigated using 
the Delta4 system and both the MPTM versions passed standard clinical gamma 
analysis criteria. Two MPTM operational setups were studied and presented in this 
article. The results indicate that both versions may be suitable for the new real-time 
megavoltage photon treatment delivery QA system under development. However, 
the bare MPTM appears to be slightly better suited of the two MP versions, as it 
minimally perturbs the radiation field and does not lead to any significant increase 
in skin dose to the patient.
PACS number(s): 87.50.up, 87.53.Bn, 87.55.N, 87.55.Qr, 87.56.Fc.
Key words: transmission detector, solid-state 2D detector array, radiotherapy quality 
assurance, surface dose, dose reconstruction, in vivo dosimetry
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I. INTRODUCTION
External photon beams such as intensity-modulated radiation therapy (IMRT) and, more recently, 
volumetric-modulated arc therapy (VMAT), which have highly conformal radiation delivery, 
have increasingly been applied for cancer treatment.(1,2) The main goal of these techniques is 
to achieve dose distribution of increased conformity to the target volumes, while further reduc-
ing the doses to the healthy normal tissue.(3) VMAT consists of treating the patient by using 
one or more gantry arcs with continuously varying beam aperture shape, gantry speed, and 
dose rate.(4,5) The complexity of IMRT and VMAT in treatment delivery places new demands 
on ensuring the quality of the linear accelerator dose delivery in real time, as its controller 
must now determine in real time the gantry position (VMAT), the multileaf collimator (MLC) 
operation, and jaw speed, as well as the dose rate (VMAT & IMRT). The complexity of the 
systems involved requires new and appropriate methods and potentially new tools in order to 
do this. Several devices dedicated to daily QA have been developed that can be used for IMRT 
and VMAT verification.(6-12)
The 2D detector arrays based on ionization chambers play a major role in QA, but most of 
these are not suitable for in vivo 2D dose mapping.(10,13-18) 2D semiconductor based on diodes 
approaches, such as MapCHECK (Sun Nuclear Corp., Melbourne, FL)(5,11,19-21) and the  quality 
control (QA) device,(22) have also been used for dose verification. Electronic portal imaging 
devices (EPIDs) have also been tested for in vivo dosimetry purposes.(12) In phantom, verifica-
tion of the treatment plan in three dimensions (3D) can be carried out successfully using  Delta4 
(Scandidos AB, Uppsala, Sweden),(23) ArcCHECK (Sun Nuclear Corp.),(5,24-26) and Octavius 
(PTW, Freiburg, Germany).(27) 
There is considerable need for real-time in vivo verification of the IMRT and the VMAT that 
can be achieved by a transmission-type detector placed in the photon beam downstream of the 
MLC during treatment. The idea of a 2D array transmission detector for real-time in vivo QA 
in external beam radiation therapy (EBRT) was first proposed by Paliwal et al.(28) The transmis-
sion chamber was an off-the-shelf device called a Dose Area Product Meter (Gammex RMI, 
Inc., Middleton, WI)(28) using the concept of dose-area product to monitor the radiation beam 
in diagnostic applications for the measurement of patient exposure. The concept of a dose-area 
product was further developed to allow online in vivo comparison of measured dose-area product 
related to instantaneous MLC leaves opening and compare it with prerecorded data.(29,30)
Most of the currently used transmission-type detectors such as the COMPASS detector (IBA 
Dosimetry),(31) the integral quality monitoring system (IQM),(30) and the DAVID system(29,32) 
are based on pixelated ionization chambers and these systems have been shown to significantly 
increase the patient surface dose due to additional electron contamination. The presence of 
these transmission devices also causes beam attenuation up to 7% for a 6 MV photon beam for 
doses beyond dmax.
(30,31,33) Recently, wireless transmission detectors, such as Delta4 Discover 
(ScandiDos) based on a 2D diode array(34) and Dolphin (IBA Dosimetry) based on a 2D ioniza-
tion chamber array,(35) have been introduced. These are very advanced in vivo QA dosimetry 
systems but clinical evaluation, and, in particular, their effect on skin dose and the perturbation 
of the radiation field still need to be evaluated. Although some of these QA delivery devices 
are available commercially, they are still rare in clinical practice for IMRT and VMAT delivery 
verification during patient daily treatment. 
We are developing a solid-state–based detector system for real-time QA during radiotherapy 
treatment, which is completely independent of the known linear accelerator operating condi-
tions. The 2D silicon transmission diode array, called the Magic Plate (MP)(36) is designed to be 
placed between the MLC and the patient, operating in transmission mode (MPTM). Therefore, 
the response of the 2D detector array can be correlated with the amount of 2D energy fluence 
incident on the patient and therefore with dose. Recently we have demonstrated possibility of 
2D dose reconstruction at different depths in a phantom for different field configurations based 
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on MPTM response.(37) The QA system will therefore provide immediate real-time feedback 
simultaneously with the patient treatment, leading to a very robust QA in treatment delivery. 
The Magic Plate has been previously reported in dose mode (MPDM) to map a 2D dose 
distribution in a phantom.(36) However, for the real-time QA system, the MP is placed in the 
accessory slot on the head of the linac and must be operated as a transmission detector during the 
patient treatment with minimal perturbation of the incident radiation field, requiring a detailed 
study of its influence on the treatment beam. The surface dose in particular can be one of the 
limiting factors in treatment plans with high doses to a target and is the focus of this work.(38) 
Similar studies in the past have been completed for beam modifiers such as wedges, MLC, and 
block trays.(39-42) Beam perturbation can be quantified by measuring changes in the percentage 
depth dose (PDD) profiles particularly in the buildup region, including surface dose, with the 
transmission MP placed in the beam. Ideally, such a device would have no significant impact 
on the treatment delivery, either to the target dose or surrounding normal tissues. Therefore, 
the main objective of this study is to quantitatively determine whether or not the presence of 
the MP upstream of the patient has a significant effect on the surface dose and PDD during 
patient treatment. 
 
II. MATERIALS AND METHODS
The Magic Plate (MP) is a 2D detector array of 11 × 11 silicon epitaxial diodes covering an area 
of 10 × 10 cm2 with a thickness of 0.45 mm, as shown in Fig. 1(a). The physical size of a single 
epidiode is 1.5 × 1.5 × 0.425 mm3. The  MP is designed to be operated in both transmission mode 
(MPTM) and dose mode (MPDM), and details of the MP design, preliminary characterization 
and the individual epitaxial silicon diodes utilized have been published elsewhere.(36,43)
For the MPTM investigation we examined two potential operational setup conditions:
(i) The MP array sandwiched between black plastic sheets, 80 μm thick, here in referred as 
“bare MPTM” as shown in Fig. 1(b). The role of the black plastic is to remove light from 
the background detector response.
(ii) The MP array with an additional 1 mm of solid water covering the entire array as shown in 
Fig. 1(c). The role of the 1 mm solid water was to remove scattered low-energy electrons.
Condition (i) is designed for minimum attenuation of the primary linac beam; however, 
precise sampling of the energy fluence may be adversely affected by contamination electrons. 
To better sample the energy fluence the 1 mm of solid water was introduced in condition (ii) 
to filter a large component of these contamination electrons. The surface dose and percentage 
depth dose (PDD) for each setup (i.e., (i) and (ii) above) was measured and compared to the 
corresponding surface dose and PDD with no MP in place (i.e., open field). These measure-
ments were carried out both in-field (on the beam central axis (CAX)) and out-of-field (OOF) 
for different field sizes. 
Experiments were performed on two Varian linear accelerators (Model 2100EX), one of 
which operated at the energies of 6 MV and 10 MV, and another which was operated at 18 MV. 
Irradiation field sizes of 5 × 5 cm2 and 10 × 10 cm2 and a constant SSD of 100 cm were used for 
both linac experiments. Ionization chamber measurements were normalized to the maximum 
dose at a depth of 15 mm for 6 MV, 21 mm for 10 MV, and 30 mm for 18 MV beam energies. 
With the MPTM mounted on the linac accessory slot, PDD up to a depth of 10 cm were mea-
sured on the central axis (CAX) and out of the field (OOF) 11 cm laterally to CAX as a function 
of the irradiation field size. For the OOF measurements, the Solid Water phantom (Gammex 
RMI, Middleton, WI) and detector on the linac patient couch were moving laterally from the 
central axis position. The phantom size was 60 × 30 × 30 cm3 with the lateral movement in the 
direction of the 60 cm phantom length to maintain consistent scattering conditions. 
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The depth-dose profile and surface dose were measured with Markus type (PTW, Freiburg, 
Germany) parallel plate ionization chamber Model N23343. The chamber was connected via 
a tri-axial cable to a PTW UNIDOS model T10002-20713 electrometer with -300 V bias volt-
age applied. The Markus chamber is designed for the measurement of surface and buildup 
dose. Markus-type chambers are known for their overresponse due to the large separation 
and their small guard ring,(44,45) and different methods have been developed to correct for this 
overresponse.(46-49) In this study, all measurements using the Markus ionization chamber were 
corrected using the Velkley correction as modified by Rawlinson to correct the overresponse of 
the Markus chamber. The chamber dimension used for the correction calculation was obtained 
from Chen et al.(50) A dose of 200 MU was used for all measurements. 
All measurements were performed with MPTM (source-to-detector distance (SDD) is 58 cm) 
for the two different setup conditions mentioned above and without MP (open field) as shown 
in Fig. 2. All measurements were repeated at least three times in order to calculate the average 
value and standard deviation. 
The depth dose as a function of field size in the solid water phantom were carried out using 
the Markus chamber mentioned above with some data compared with that using an Attix 
chamber (Gammex RMI), RMI model 449 for the same measurements.
Fig. 1. Magic Plate 2D diode array is shown. Magic Plate (MP) (a), designed at CMRP, University of Wollongong, with 
two possible setup conditions: (b) the bare MP array (sandwiched between black 80 μm thick plastic sheets), and (c) the 
bare MP array (covered by 1 mm solid water through entire MP).
(a) (b) (c)
Fig. 2. Transmission mode Magic Plate setup. MPTM, just below the linac jaw of the medical linear accelerator with a 
prototype version of the MP readout system on the head of a Varian linac.
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In the second part of this study, the influence of both the bare MPTM and the MPTM with 
1 mm buildup on the open field 3D dose distribution (measured change as a percentage) was 
measured by the Delta4 (Scandidos AB) QA system.
Different treatment field configurations were used using the Delta4 system positioned at 
isocenter for both MPTM versions to study Delta4 response in comparison with open field. A 
6 MV photon beam and different treatment configurations were used for both MPTM versions 
(bare MPTM and MPTM with 1 mm buildup). The center of the Delta4 phantom was aligned 
at isocenter using the relevant markings on the PMMA. A daily correction factor (DCF) was 
applied to Delta4 system measurements in order to account for differences in treatment  conditions 
between the time of calibration and time of measurement. The DCF is calculated for a uniform, 
square field 20 × 20 cm2. The relevant DCF has been applied to all measurements. Prior to 
calculation of the DCF, the temperature is measured on the surface of the electrometer unit. 
The correction is calculated relative to the temperature at the time of absolute calibration. The 
temperature is input to the software and a correction is applied internally. 
In the third part of this work, we investigated the transmission factor of the MP. The trans-
mission factor was derived from any dose change measured at dmax and at a depth of 10 cm 
for radiation field sizes 10 × 10 cm2 and 5 × 5 cm2 and an SSD of 100 cm for 6 MV, 10 MV, 
and 18 MV photon fields. A Farmer ionization chamber (Model 2571A) was used for 6 MV, 
10 MV, and an Attix chamber, Model 449, was used for the 18 MV. Delta4 system also was used 
to measure the transmission characteristics for 6 MV photon beam using different treatment 
configurations for both MP versions in comparison with the open field configuration. 
 
III. RESULTS 
Figure 3 shows the depth dose profile of a 6 MV photon beam on the CAX and OOF for a 10 × 
10 cm2 and 5 × 5 cm2 field size, respectively, with the bare MPTM (setup (i)) mounted in the 
linac accessory. Error bars (where visible) represent 3 SDs from the mean. The square symbols 
in each graph show the measured change (plotted separately) in the depth-dose curve (DDC) 
caused by the MPTM in the beam. 
Figures 3(a) and (c) demonstrate that the perturbation effect of the radiation beam by MPTM 
is negligible. The change in the surface dose with the MPTM placed in the beam was a reduction 
of 0.0751 cGy (0.2270%) for 10 × 10 cm2 and an increase of 0.1553 cGy (0.6125%) for 5 × 
5 cm2 field sizes. For all depths investigated, the maximum measured change in the absolute dose 
was a reduction of less than 0.2839 cGy (0.1647%) for 10 × 10 cm2 and 0.2769 cGy (0.2363%) 
for 5 × 5 cm2 field sizes. The majority of the change occurs within 5 mm of the surface. The 
measured changes in the CAX dose at any depths with MPTM in a beam were less than 1% of 
the equivalent open field value. The similar experiments on the 6 MV beam  using the MPTM 
with additional 1 mm buildup showed an increase of the surface dose 0.9776 cGy (2.9554%) 
for 10 × 10 cm2 and 0.1001 cGy (0.3910%) for 5 × 5 cm2 field sizes.
In the case of the OOF, the effect of the MPTM on radiation field perturbation is greater 
in terms of percentage change than for the equivalent CAX measurements. In addition, the 
majority of the change occurs within 10 mm below the phantom surface. With MPTM placed 
in the beam, the surface dose increased by 0.1076 cGy (1.4997%) for the 10 × 10 cm2 and 0. 
1051 cGy (6.2561%) 5 × 5 cm2 field sizes, as shown in Figs. 3(b) and (d). The equivalent using 
the MPTM with an additional 1 mm solid water buildup showed 0.8031 cGy (10.8580%) for 
10 × 10 cm2 and 0. 2914 cGy (16.9675%) for 5 × 5 cm2 field sizes.
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Figure 4 shows the depth-dose profile of the 10 MV photon beam on the CAX and OOF 
for 10 × 10 cm2 and 5 × 5 cm2 field sizes with the bare MPTM (setup (i)) mounted in the linac 
accessory. 
Similar to the 6 MV X-ray beam, the perturbation effect of the bare MPTM is small. The 
change in the surface dose by the introduction of the MPTM was a reduction of 0.3576 cGy 
(1.5604%) for 10 × 10 cm2 and 0. 1097 cGy (0.7140%) for 5 × 5 cm2 field sizes. 
From Figs. 4(a) and (c) one can see that, for all depths investigated, the maximum measured 
change in absolute dose was less than -0.9138 cGy (-0.5778%) and -0.3045 cGy (-0.2322%) for 
the 10 × 10 cm2 and 5 × 5 cm2 field sizes, respectively. The greatest dose change occurs within 
7 mm of the surface. The perturbation effect of MPTM on the depth-dose change in the CAX 
is less than 1% for all measured depths. A similar experiment with 1 mm solid water buildup 
placed above the MPTM showed an increase of the surface dose by +0.3280 cGy (+1.4345%) 
and +0.0552 cGy (+0.3576%) for 10 × 10 cm2 and 5 × 5 cm2 field sizes, respectively.
In OOF, the perturbation effect of the MPTM on depth-dose distribution is slightly higher 
than for the same dose in a CAX. Most dose change is within 10 mm from the surface. The 
surface dose with MPTM in the beam decreased slightly -0.0938 cGy (-1.2412%) for 10 cm × 
10 cm2 and increased +0.0702 cGy (+3.7167%) for the 5 × 5 cm2 field sizes. The equivalent 
experiments using the MPTM with an additional 1 mm buildup showed an increase of the 
Fig. 3. Depth-dose measurements at 6 MV. Depth dose and dose difference distributions in a solid water phantom for a 
6 MV linac field, SSD 100 cm, with and without MPTM, for different field sizes on the CAX: (a) 10 × 10 cm2, (c) 5 × 
5 cm2; and OOF field sizes (b) 10 × 10 cm2, (d) 5 × 5 cm2. The solid circles indicate that the response of ionization cham-
ber when MP was operated in transmission mode, and the open circles indicate the response of the ionization chamber 
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surface dose +0.5858 cGy (+7.5330%) and +0.3749 cGy (+20.2024%) for 10 × 10 cm2 and 
5 × 5 cm2 field sizes, respectively.
Figure 5 shows the depth-dose profile of an 18 MV photoneutron beam on the CAX and 
OOF for 10 × 10 cm2 and 5 × 5 cm2 field sizes with the bare MPTM (setup (i)) mounted in the 
linac accessory. 
As for 6 MV and 10 MV X-ray beams, the perturbation effect of the bare MPTM is small. 
The change in the surface dose by the MPTM was -1.8991 cGy (-6.3814%) for 10 × 10 cm2 
and -0.8535 cGy (-6.2781%) for 5 × 5 cm2 field sizes. 
From Figs. 5(a) and (c) one can see that, for all depths investigated, the maximum measured 
change in absolute dose was less than +0.4773 cGy (+0.3013%) and +0.3947 cGy (+0.2025%) 
for the 10 × 10 cm2 and 5 × 5 cm2 field sizes, respectively. The most dose change occurs within 
10 mm from the surface. The perturbation effect of MPTM on depth-dose change in the CAX 
is less than 1% for all measured depths. A similar experiment with 1 mm solid water buildup 
placed above the MPTM showed an increase of surface dose of -2.4356 cGy (-8.1842%) and 
-1.0862 cGy (-7.9895%) for 10 × 10 cm2 and 5 × 5 cm2 field sizes, respectively.
In OOF, the perturbation effect of the MPTM on depth-dose distribution is slightly higher 
than in a field. Most dose change is within 10 mm of the surface. The surface dose with MPTM 
Fig. 4. Depth-dose measurements at 10 MV. Depth dose and dose difference distributions in a solid water phantom for 
10 MV linac field, SSD 100 cm, with and without MPTM, for different field sizes on the CAX: (a) 10 × 10 cm2, (c) 5 × 
5 cm2; and OOF field sizes (b) 10 × 10 cm2, (d) 5 × 5 cm2. The solid circles indicate that the response of ionization cham-
ber when MP was operated in transmission mode, and the open circles indicate the response of the ionization chamber 
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in the beam slightly decreased by 0.3169 cGy (-3.4432%) for 10 × 10 cm2 and decreased by 
0. 04476 cGy (-1.9931%) for the 5 × 5 cm2 field sizes. The equivalent experiments using the 
MPTM with additional 1 mm buildup showed a decrease in  the surface dose of 0.1804 cGy 
(-1.9631%) and an increase of 0.08228 cGy (+3.6623%) for 10 × 10 cm2 and 5 × 5 cm2 field 
size, respectively. 
Table 1 summarizes the findings of the beam perturbation by MPTM at dmax for all the 
above-presented radiation fields.
The quantitative absolute response (in nC per 100 MU) of the bare MPTM and the MPTM 
array with the additional 1 mm of solid water were measured for a 10 × 10 cm2 and 5 × 5 cm2 
field sizes and beam energies of 6 MV, 10 MV, and 18 MV. The data are presented in Table 2. 
As expected, 1 mm buildup is increasing the response of the diodes, however the signal is 
enough in both cases to reliably measure signal with accuracy better than 0.1% with developed 
512 channel electrometer. 
Figure 6 shows the effect of having the MPTM system in place on the measured 2D dose 
mapping by the Delta4 phantom diode array for a range of treatment field configurations. All data 
presented here are with the MP in transmission mode (the bare MPTM or MPTM with 1 mm 
buildup) with the data compared to the open field configuration with no MPTM in place. The 
measured changes in percent difference across the entire Delta4 detectors have been displayed 
Fig. 5. Depth-dose measurements at 18 MV. Depth dose and dose difference distributions in a solid water phantom for 
18 MV linac field, SSD 100 cm, with and without MPTM, for different field sizes in CAX: (a) 10 × 10 cm2, (c) 5 × 5 cm2; 
and OOF field sizes (b) 10 × 10 cm2, (d) 5 × 5 cm2. The solid circles indicate that the response of ionization chamber 
when MP was operated in transmission mode and the open circles indicate the response of the ionization chamber without 
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in Fig. 6. In the case of the bare MPTM, the measured change in-field in percent difference 
(2 SDs) were ± 3.24%, ± 2.77%, ± 1.97%, ± 2.75%, and ± 2.72% for the 3 × 3 cm2, 5 × 5 cm2, 
10 × 10 cm2, the beam segments, and modulated IMRT field configurations, respectively, for 
6 MV photon beam. A similar experiment with 1 mm solid water buildup placed above the 
MPTM showed that the in-field measured change in percent difference (2 SDs) were ± 3.47%, 
± 0.62%, ± 2.05%, ± 3.39%, and ± 3.10% for the 3 × 3 cm2, 5 × 5 cm2, 10 × 10 cm2, the beam 
segments, and modulated IMRT beam configurations, respectively, for 6 MV photon beam.
Gamma analysis was performed using 3% and 3 mm criteria. By comparing the planned 
dose to the delivered dose, a plan will fail the criteria if < 90% of all data points have a gamma 
index ≤ 1. Gamma analysis criteria (± 3% dose deviation, ≤ 3 mm distance to agreement and 
≤ 1 gamma index) for both MPTM setups (i and ii) and open field for all configurations of 
delivered radiation fields was carried out based on comparison of 3D doses reconstructed by  the 
Delta4 system in comparison with 3D dose predicted by treatment planning system (TPS). The 
gamma index gave 100% (90%) pass criteria for all treatment configurations. Hence, this gamma 
threshold was not sensitive to the inclusion of the bare MPTM or MPTM with 1 mm buildup.
The transmission factor related to the dose change at dmax and 10 cm depth in a solid water 
phantom for two field sizes (10 × 10 cm2 and 5 × 5 cm2) for 6 MV, 10 MV, and 18 MV energy 
Table 1. Summary of the percentage depth dose (PDD) measurements with different energies. 
 Original Markus Ionization Chamber Attix Ionization Chamber
 CAX (%) OOF (%) CAX (%) OOF (%)
	 	 	 	 MP	field	 	 MP	field	 	 MP	field	 	 MP	field
	 	 Field	 MP	field	 with	 MP	field	 with	 MP	field	 with	 MP	field	 with
 Energy Size no 1 mm no 1 mm no 1 mm no 1 mm
 (MV) (cm2) buildup buildup buildup buildup buildup buildup buildup buildup
 6 10×10 - 0.0375 0.4888 0.0538 0.4015 0.0767 0.4610 0.0485 0.3563  5×5 0.0776 0.0500 0.0525 0.1457 0.0157 0.1505 0.0312 0.1473
 10 10×10 -0.1780 0.1640 -0.0469 0.2929 -0.2559 0.1444 -0.0483 0.2428  5×5 -0.0548 0.0276 0.0351 0.1874 -0.0720 0.0527 0.0221 0.1195
 18 10×10 …. …. …. …. -0.9495 -1.2178 -0.1584 -0.0902  5×5 …. …. …. …. -0.4267 -0.5431 -0.0223 0.0411
Table 2. Summary of the response (sensitivity) (2 SDs) of the MP in transmission mode (MPTM). 
MPTM Central Diode Response (nC)
	Energy	 Field	Size	 MP	field	 MP	field	with
 (MV) (cm2) no buildup 1 mm buildup
 
6
 10×10 68.0281 72.4019   (±0.0257) (±0.1270)
  5×5 57.0172 65.3595   (±0.2208) (±0.0253)
 
10
 10×10 55.0714 73.5076   (±0.0779) (±0.0372)
  5×5 39.1567 59.1128   (±0.0053) (±0.0056)
 
18
 10×10 53.8847 61.9483   (±0.2306) (±0.1526)
  5×5 34.7484 46.4496   (±0.0304) (±0.0776)
The absolute response (in nano-Coulombs per 100 MU) of the central detector (CAX) of the MPTM  located on the 
central axis of the 6 MV, 10 MV, and 18 MV radiation fields, as a function of field size.
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Figure 6. Impact on the measured dose (in percentage difference) by Delta4® phantom for a variety of treatment field configurations. All data 


















Fig. 6. Impact on the measured dose (in percentage difference) by Delta4 phantom for a variety of treatment field con-
figurations. All data shown are with MP in transmission mode (bare MPTM or MPTM with 1 mm buildup) comparison 
with no MP in place.
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beams were measured and are presented in Table 3. Transmission factors at dmax and a depth 
of 10 cm were all within 1.630% of open field. This increases the rigidity and potential life-
time reliability of the MP system. In the case of transmission detectors, both the IQM system 
and the DAVID system attenuate a 6 MV photon beam by 7%, while the COMPASS system 
reported a 3.3% beam attenuation, which are both greater than the values measured for the MP 
system. The recently introduced ScandiDos Delta4 Discover system attenuates the beam by up 
to 1%,(34) whereas no data have yet been reported for the IBA Dolphin detector.
The transmission characteristics for 6 MV photon beam using different treatment configura-
tions for both MPTM versions in comparison with the open field configuration was measured 
by Delta4 system at isocenter by finding difference in signals measured by all corresponding 
diodes in a field. In the case of the bare MPTM, the measured in-field transmission factors (2 
SDs) were 0.9902 (± 3.24%), 0.9931 (± 2.76%), 0.9950 (± 1.96%), 0.9968 (± 2.74%), and 0.9984 
(± 2.72%) for the 3 × 3 cm2, 5 × 5 cm2, 10 × 10 cm2, the beam segments, and modulated IMRT 
field configurations, respectively, for 6 MV photon beam. A similar experiment with 1 mm solid 
water buildup placed above the MPTM showed that the in-field measured transmission factors 
(2 SDs) were 0.9835 (± 3.46%), 0.9829 (± 0.62%), 0.9850 (± 2.04%), 0.9863 (± 3.38%), and 
0.9873 (± 3.1%) for the 3 × 3 cm2, 5 × 5 cm2, 10 × 10 cm2, the beam segments, and modulated 
IMRT beam configurations, respectively, for 6 MV photon beam. These transmission character-
istics measured are similar to those measured by an ionization chamber, as quoted in Table 3.
 
IV. DISCUSSION
Two potential operational setup conditions of the MPTM were considered to investigate the 
perturbation of the radiation field, the first with a Magic Plate covered by a thin 80 μm layer 
of light protection plastic and the second with an additional 1 mm solid water buildup on top 
of the MPTM. The 1 mm solid water buildup was introduced to reduce the sensitivity of the 
MPTM response to contamination electrons from the source and scattered from the jaws, thus 
making correlation with the energy fluence less challenging. 
Results suggest that for the majority of the radiation fields studied, the electrons produced 
from the interaction of the 6 MV and the 10 MV photons with the jaws are scattered. Most of 
these electrons are peaked forward and located close to the jaw surfaces, minimizing any con-
tribution to the center of the 10 × 10 cm2 field at the phantom surface. This is supported by the 
Table 3. The transmission factor (2 SDs) at depth of dmax and at depth of 10 cm for 6 MV, 10 MV, and 18 MV energy 
beams. 
 At Depth of Maximum Dose At Depth of 10 cm
	Energy	 Field	Size	 MP	field	 MP	field	with	 MP	field	 MP	field	with
 (MV) (cm2) no buildup 1 mm buildup no buildup 1 mm buildup
 6
  10×10 0.9937 0.9841 0.9944 0.9855   (±0.0026) (±0.0021) (±0.0068) (±0.0028)
  5×5 0.9951 0.9853 0.9967 0.9845   (±0.0028) (±0.0017) (±0.0030) (±0.0019)
 10
  10×10 0.9944 0.9863 0.9949 0.9867   (±0.0012) (±0.0022) (±0.0003) ( > ± 0.0000)
  5×5 0.9948 0.9865 0.9951 0.9865   (±0.0010) (±0.0006) (±0.0005) (±0.0006)
 18 
 10×10 0.9930 0.9856 0.9959 0.9901   (±0.0006) (±0.0007) (±0.0002) (±0.0001)
  5×5 0.9943 0.9902 0.9964 0.9853   (±0.0004) (±0.0006) (±0.0002) (±0.0004)
The Farmer ionization chamber was used for 6 MV and 10 MV and the Attix chamber was used for 18 MV.
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increase in the relative surface dose when adding a 1 mm solid water slab above the MP which 
acts as a buildup for photons and an attenuator of scattered low-energy electrons. However, 
in the case of a 5 × 5 cm2 field, the role of electrons scattered from the jaw to the center of the 
field is essential. This is supported by a small change in the relative surface dose caused by 
the addition of the 1 mm slab above the MP. This effect is a combination of the attenuation of 
the low-energy electrons scattered from the jaws and the generation of electrons from direct 
photon interactions within the 1 mm solid water buildup. 
It was demonstrated that the OOF surface dose enhancement produced by a 1 mm buildup 
was greater than when the bare MPTM was used. This result is consistent with the CAX mea-
surements and supports the radiation field perturbation interpretations on the CAX. The CAX 
and OOF dose with depth with the bare MPTM (Figs. 3 to 5) in place shows that the MPTM 
has negligible effect otherwise for all investigated fields and photon energies. The depth-dose 
distribution perturbation is less than 1% at any depth, less than 10 cm in solid water. Perturbation 
factors at dmax and at a depth of 10 cm were found to be less than 1.63% of the open field for 
all energies tested. The MPTM therefore produces very minimal distortion of the field and skin 
dose, both in field and OOF. Monte Carlo simulations are required for detailed explanation 
of the observed dose reduction and enhancement due to the MPTM which will form part of 
future work.   
 
V. CONCLUSIONS
The impact of the black plastic sheet and the 1 mm of solid water on the changes in the skin 
dose and full PDD have been investigated. The results showed that in general, both versions of 
the MPTM detector array could potentially be used as a 2D transmission detector. However, if 
the surface dose considered as an important factor to be considered for the cancer treatment, 
then the bare MPTM proved to be the best candidate as the increase to the surface dose was 
the least of the two systems tested.
The design of the MP (detectors and packaging) has been shown to be suitable for mounting 
the full QA device in the linac accessory slot during patient radiotherapy treatment. We have 
demonstrated that at 6 MV, 10 MV, and 18 MV the MPTM in the beam minimally perturbs 
the radiation field both in a field and out of field, leading to a < 0.5% increase in dose at the 
surface relative to dose at dmax and < 1% in depth of the phantom. This change is minimal and 
within any dosimetry budgeted error, while potentially allowing for real-time verification of 
VMAT and IMRT during patient treatment. Further work will be directed to the conversion of 
the response of MPTM directly to the absorbed dose in a patient without using the beam model.
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